http://www.cnr.it/ontology/cnr/individuo/unitaDiPersonaleInterno/MATRICOLA8163
ANTONINA AZZOLINA
- Type
- Label
- ANTONINA AZZOLINA (literal)
- ANTONINA AZZOLINA (literal)
- Partecipa a commessa
- Persona in rapporto
- Autore CNR di
- Novel combination of celecoxib and proteasome inhibitor MG132 provides synergistic antiproliferative and proapoptotic effects in human liver tumor cells. Cell Cycle. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Potentiation of the antitumor effects of both selective cyclooxygenase-1 and cyclooxygenase-2 inhibitors in human hepatic cancer cells by inhibition of the MEK/ERK pathway (Articolo in rivista) (Prodotto della ricerca)
- Aromatase and amphiregulin are correspondingly expressed in human liver cancer cells. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Gene expression profiling of human liver cancer cells following celecoxib treatment. (Abstract/Poster in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1302)
- Altered gene expression profiles in liver cancer cells upon sorafenib treatment. (Abstract/Poster in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1302)
- Solid lipid nanoparticles (SLNs) containing nimesulide: preparation, characterization and in cytotoxicity studies (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- The response to simulated hypogravity is dependent on the proliferation state and temperature in FRTL-5 thyroid cells (Abstract/Poster in atti di convegno) (Prodotto della ricerca)
- Combination treatment with celecoxib and DHMEQ or curcumin results in synergistic cell growth inhibition in hepatic cancer cells. (Contributo in atti di convegno) (Prodotto della ricerca)
- Prostaglandin E2 receptors and COX enzymes in human hepatocellular carcinoma: role in the regulation of cell growth. (Contributo in atti di convegno) (Prodotto della ricerca)
- Solid-lipid nanoparticles for gene delivery to cells. (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- The selective COX-1 inhibitor SC-560 inhibits cell growth and induces apoptosis in human hepatocellular carcinoma cells. (Contributo in atti di convegno) (Prodotto della ricerca)
- Nanostructured lipid carriers-containing anticancer compounds: preparation, characterization, and cytotoxicity studies (Articolo in rivista) (Prodotto della ricerca)
- Novel combination of sorafenib and celecoxib provides synergistic anti-proliferative and pro-apoptotic effects in human liver cancer cells. (Articolo in rivista) (Prodotto della ricerca)
- Development of nimesulide loaded solid lipid nanoparticles. (Abstract/Poster in atti di convegno) (Prodotto della ricerca)
- Growth suppression and apoptosis induction in human hepatoma cells by DHMEQ, a novel NF-KB inhibitor, is mediated through a ROS-dependent mechanism. (Abstract/Poster in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1302)
- The multikinase inhibitor Sorafenib exhibits a strong cytotoxic effect in liver cancer cells through a MEK/ERK signaling-independent mechanism (Abstract/Poster in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1302)
- Altered gene expression profiles in liver cancer cells upon sorafenib treatment. (Abstract/Poster in convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1304)
- Combination of DHMEQ and Celecoxib synergistically exert anti-tumoral effects in human hepatoma cells. (Abstract/Poster in convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1304)
- G. Prostaglandin E2 receptors and COX enzymes in human hepatocellular carcinoma: role in the regulation of cell growth. (Abstract/Poster in convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1304)
- DHMEQ and Celecoxib synergistically exert anti-tumoral activities in human liver cancer cells. (Abstract/Poster in convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1304)
- The novel NF-kB inhibitor DHMEQ suppresses the growth of human hepatic cancer cells through redox-dependent signaling. (Abstract/Poster in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1302)
- Targeted therapy for hepatocellular carcinoma: novel agents on the horizon. (Articolo in rivista) (Prodotto della ricerca)
- The novel NF-kB inhibitor DHMEQ synergizes with celecoxib to exert antitumor effects on human liver cancer cells by a ROS-dependent mechanism. (Articolo in rivista) (Prodotto della ricerca)
- Substance P induces TNF-alpha and IL-6 production through NFkB in peritoneal mast cells (Articolo in rivista) (Prodotto della ricerca)
- INVOLVEMENT OF p38 AND JNK mapks PATHWAYS IN SUBSTANCE P-INDUCED PRODUCTION OF TNF - BY PERITONEAL MAST CELLS (Articolo in rivista) (Prodotto della ricerca)
- Microgravity and cellular homeostasis: effects of simulated hypogravity on FRTL-5 thyroid cells. (Abstract/Poster in convegno) (Prodotto della ricerca)
- Antitumor effects of the selective cyclooxygenase-1 inhibitor SC-560 is potentiated by inhibiton of MEK/ERK pathway in human hepatocellular carcinoma cells (Abstract/Poster in convegno) (Prodotto della ricerca)
- Potentiation of antitumor effects of NSAIDs by inhibition of MEK/ERK activity in human hepatocellular carcinoma cells (Abstract/Poster in convegno) (Prodotto della ricerca)
- The selective COX-1 inhibitor SC-560 suppresses cell growth and induces apoptosis in human hepatocellular carcinoma cells (Abstract/Poster in convegno) (Prodotto della ricerca)
- Synthesis and characterization of polyaminoacidic polycations for gene delivery. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- The selective cyclooxygenase-1 inhibitor SC-560 suppresses cell proliferation and induces apoptosis in human hepatocellular carcinoma cells (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Cationic solid-lipid nanoparticles for gene delivery. (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- Molecular mechanisms of sorafenib action in liver cancer cells. (Articolo in rivista) (Prodotto della ricerca)
- Combination of the selective COX-2 inhibitor Celecoxib and the proteasome inibitor MG132 synergistically induces anti-proliferative and pro-apoptotic activity in liver cancer cells: possible involvement of endoplasmic reticulum stress response. (Abstract/Poster in convegno) (Prodotto della ricerca)
- DHMEQ, a novel NF-kb inhibitor, anticancer activity through induction of reactive oxygen species-dependent mechanism in human hepatoma cells. (Abstract/Poster in convegno) (Prodotto della ricerca)
- Combination of the selective COX-2 inhibitor Celecoxib and the proteasome inibitor MG132 synergistically induces anti-proliferative and pro-apoptotic activity in liver cancer cells: possible involvement of endoplasmic reticulum stress response. (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- Cationic Solid-lipid nanoparticles as DNA carriers. (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- The selective COX-1 inhibitor SC-560 inhibits cell growth and induces apoptosis in human hepatocellular carcinoma cells (Abstract/Poster in convegno) (Prodotto della ricerca)
- Influence of MEK/ERK signaling on apoptosis induced by selective cyclooxygenase-1 and cyclooxygenase-2 inhibitors in human hepatocellular carcinoma cells. (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- Inhibition of MEK/ERK pathway enhances apoptosis induced by selective COX-1 and COX-2 inhibitors in human hepatocellular carcinoma cells. (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- Potentiation of antitumor effects of NSAIDs by inhibition of MEK/ERK activity in human hepatocellular carcinoma cells. (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- The selective COX-1 inhibitor SC-560 suppresses cell growth and induces apoptosis in human hepatocellular carcinoma cells. (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- Influence of MEK/ERK signaling on apoptosis induced by selective cyclooxygenase-1 and cyclooxygenase-2 inhibitors in human hepatocellular carcinoma cells (Abstract/Poster in convegno) (Prodotto della ricerca)
- Inhibition of MEK/ERK pathway enhances apoptosis induced by selective COX-1 and COX-2 inhibitors in human hepatocellular carcinoma cells. (Abstract/Poster in convegno) (Prodotto della ricerca)
- Combination treatment with celecoxib and DHMEQ or curcumin results in synergistic cell growth inhibition in hepatic cancer cells (Abstract/Poster in atti di convegno) (Prodotto della ricerca)
- DHMEQ, a novel NF-kb inhibitor, anticancer activity through induction of reactive oxygen species-dependent mechanism in human hepatoma cells. (Contributo in atti di convegno) (Prodotto della ricerca)
- Microgravity and cellular homeostasis:effects of stimulated hypogravity on FRTL-5 thyroid cells. (Contributo in atti di convegno) (Prodotto della ricerca)
- Antitumor effects of the selective cyclooxygenase-1 inhibitor SC-560 is potentiated by inhibiton of MEK/ERK pathway in human hepatocellular carcinoma cells. (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- Novel cationic solid-lipid nanoparticles as non-viral vectors for gene delivery (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Histamine and spontaneously released mast cell granules affect the cell growth of human hepatocellular carcinoma cells (Articolo in rivista) (Prodotto della ricerca)
- COX-2-Dependent and COX-2-Independent Mode of Action of Celecoxib in Human Liver Cancer Cells. (Articolo in rivista) (Prodotto della ricerca)
- Expression of WISPs and of their novel alternative variants in human hepatocellular carcinoma cells. (Articolo in rivista) (Prodotto della ricerca)
- Antitumor effects of DHMEQ, a novel NF-kB inhibitor, in human liver cancer cells is mediated through a reactive oxygen species-dependent mechanism. (Articolo in rivista) (Prodotto della ricerca)
- Prostaglandin E2 receptors and COX enzymes in human hepatocellular carcinoma: role in the regulation of cell growth. (Articolo in rivista) (Prodotto della ricerca)
- Solid Lipid Nanoparticles Containing Nimesulide: Preparation, Characterization and Cytotoxicity Studies. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Coautore
- Nome
- Cognome
- Afferisce a
- Ha pubblicazioni con
Incoming links:
- Autore CNR
- The selective COX-1 inhibitor SC-560 inhibits cell growth and induces apoptosis in human hepatocellular carcinoma cells. (Contributo in atti di convegno) (Prodotto della ricerca)
- Solid-lipid nanoparticles for gene delivery to cells. (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- Combination treatment with celecoxib and DHMEQ or curcumin results in synergistic cell growth inhibition in hepatic cancer cells. (Contributo in atti di convegno) (Prodotto della ricerca)
- Prostaglandin E2 receptors and COX enzymes in human hepatocellular carcinoma: role in the regulation of cell growth. (Contributo in atti di convegno) (Prodotto della ricerca)
- Antitumor effects of the selective cyclooxygenase-1 inhibitor SC-560 is potentiated by inhibiton of MEK/ERK pathway in human hepatocellular carcinoma cells. (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- Microgravity and cellular homeostasis:effects of stimulated hypogravity on FRTL-5 thyroid cells. (Contributo in atti di convegno) (Prodotto della ricerca)
- DHMEQ, a novel NF-kb inhibitor, anticancer activity through induction of reactive oxygen species-dependent mechanism in human hepatoma cells. (Contributo in atti di convegno) (Prodotto della ricerca)
- The selective cyclooxygenase-1 inhibitor SC-560 suppresses cell proliferation and induces apoptosis in human hepatocellular carcinoma cells (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Synthesis and characterization of polyaminoacidic polycations for gene delivery. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Aromatase and amphiregulin are correspondingly expressed in human liver cancer cells. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Novel combination of celecoxib and proteasome inhibitor MG132 provides synergistic antiproliferative and proapoptotic effects in human liver tumor cells. Cell Cycle. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- COX-2-Dependent and COX-2-Independent Mode of Action of Celecoxib in Human Liver Cancer Cells. (Articolo in rivista) (Prodotto della ricerca)
- Histamine and spontaneously released mast cell granules affect the cell growth of human hepatocellular carcinoma cells (Articolo in rivista) (Prodotto della ricerca)
- INVOLVEMENT OF p38 AND JNK mapks PATHWAYS IN SUBSTANCE P-INDUCED PRODUCTION OF TNF - BY PERITONEAL MAST CELLS (Articolo in rivista) (Prodotto della ricerca)
- Substance P induces TNF-alpha and IL-6 production through NFkB in peritoneal mast cells (Articolo in rivista) (Prodotto della ricerca)
- Potentiation of the antitumor effects of both selective cyclooxygenase-1 and cyclooxygenase-2 inhibitors in human hepatic cancer cells by inhibition of the MEK/ERK pathway (Articolo in rivista) (Prodotto della ricerca)
- Expression of WISPs and of their novel alternative variants in human hepatocellular carcinoma cells. (Articolo in rivista) (Prodotto della ricerca)
- Solid Lipid Nanoparticles Containing Nimesulide: Preparation, Characterization and Cytotoxicity Studies. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Prostaglandin E2 receptors and COX enzymes in human hepatocellular carcinoma: role in the regulation of cell growth. (Articolo in rivista) (Prodotto della ricerca)
- Antitumor effects of DHMEQ, a novel NF-kB inhibitor, in human liver cancer cells is mediated through a reactive oxygen species-dependent mechanism. (Articolo in rivista) (Prodotto della ricerca)
- Solid lipid nanoparticles (SLNs) containing nimesulide: preparation, characterization and in cytotoxicity studies (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Potentiation of antitumor effects of NSAIDs by inhibition of MEK/ERK activity in human hepatocellular carcinoma cells. (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- The selective COX-1 inhibitor SC-560 suppresses cell growth and induces apoptosis in human hepatocellular carcinoma cells. (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- Inhibition of MEK/ERK pathway enhances apoptosis induced by selective COX-1 and COX-2 inhibitors in human hepatocellular carcinoma cells. (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- Cationic Solid-lipid nanoparticles as DNA carriers. (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- Influence of MEK/ERK signaling on apoptosis induced by selective cyclooxygenase-1 and cyclooxygenase-2 inhibitors in human hepatocellular carcinoma cells. (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- Combination of the selective COX-2 inhibitor Celecoxib and the proteasome inibitor MG132 synergistically induces anti-proliferative and pro-apoptotic activity in liver cancer cells: possible involvement of endoplasmic reticulum stress response. (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- Potentiation of antitumor effects of NSAIDs by inhibition of MEK/ERK activity in human hepatocellular carcinoma cells (Abstract/Poster in convegno) (Prodotto della ricerca)
- Antitumor effects of the selective cyclooxygenase-1 inhibitor SC-560 is potentiated by inhibiton of MEK/ERK pathway in human hepatocellular carcinoma cells (Abstract/Poster in convegno) (Prodotto della ricerca)
- Growth suppression and apoptosis induction in human hepatoma cells by DHMEQ, a novel NF-KB inhibitor, is mediated through a ROS-dependent mechanism. (Abstract/Poster in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1302)
- The novel NF-kB inhibitor DHMEQ suppresses the growth of human hepatic cancer cells through redox-dependent signaling. (Abstract/Poster in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1302)
- DHMEQ and Celecoxib synergistically exert anti-tumoral activities in human liver cancer cells. (Abstract/Poster in convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1304)
- Altered gene expression profiles in liver cancer cells upon sorafenib treatment. (Abstract/Poster in convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1304)
- Combination of DHMEQ and Celecoxib synergistically exert anti-tumoral effects in human hepatoma cells. (Abstract/Poster in convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1304)
- The multikinase inhibitor Sorafenib exhibits a strong cytotoxic effect in liver cancer cells through a MEK/ERK signaling-independent mechanism (Abstract/Poster in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1302)
- The selective COX-1 inhibitor SC-560 suppresses cell growth and induces apoptosis in human hepatocellular carcinoma cells (Abstract/Poster in convegno) (Prodotto della ricerca)
- Microgravity and cellular homeostasis: effects of simulated hypogravity on FRTL-5 thyroid cells. (Abstract/Poster in convegno) (Prodotto della ricerca)
- G. Prostaglandin E2 receptors and COX enzymes in human hepatocellular carcinoma: role in the regulation of cell growth. (Abstract/Poster in convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1304)
- The selective COX-1 inhibitor SC-560 inhibits cell growth and induces apoptosis in human hepatocellular carcinoma cells (Abstract/Poster in convegno) (Prodotto della ricerca)
- Inhibition of MEK/ERK pathway enhances apoptosis induced by selective COX-1 and COX-2 inhibitors in human hepatocellular carcinoma cells. (Abstract/Poster in convegno) (Prodotto della ricerca)
- Influence of MEK/ERK signaling on apoptosis induced by selective cyclooxygenase-1 and cyclooxygenase-2 inhibitors in human hepatocellular carcinoma cells (Abstract/Poster in convegno) (Prodotto della ricerca)
- Combination of the selective COX-2 inhibitor Celecoxib and the proteasome inibitor MG132 synergistically induces anti-proliferative and pro-apoptotic activity in liver cancer cells: possible involvement of endoplasmic reticulum stress response. (Abstract/Poster in convegno) (Prodotto della ricerca)
- DHMEQ, a novel NF-kb inhibitor, anticancer activity through induction of reactive oxygen species-dependent mechanism in human hepatoma cells. (Abstract/Poster in convegno) (Prodotto della ricerca)
- The response to simulated hypogravity is dependent on the proliferation state and temperature in FRTL-5 thyroid cells (Abstract/Poster in atti di convegno) (Prodotto della ricerca)
- Gene expression profiling of human liver cancer cells following celecoxib treatment. (Abstract/Poster in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1302)
- Altered gene expression profiles in liver cancer cells upon sorafenib treatment. (Abstract/Poster in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1302)
- Cationic solid-lipid nanoparticles for gene delivery. (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- Nanostructured lipid carriers-containing anticancer compounds: preparation, characterization, and cytotoxicity studies (Articolo in rivista) (Prodotto della ricerca)
- Combination treatment with celecoxib and DHMEQ or curcumin results in synergistic cell growth inhibition in hepatic cancer cells (Abstract/Poster in atti di convegno) (Prodotto della ricerca)
- Novel cationic solid-lipid nanoparticles as non-viral vectors for gene delivery (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Molecular mechanisms of sorafenib action in liver cancer cells. (Articolo in rivista) (Prodotto della ricerca)
- The novel NF-kB inhibitor DHMEQ synergizes with celecoxib to exert antitumor effects on human liver cancer cells by a ROS-dependent mechanism. (Articolo in rivista) (Prodotto della ricerca)
- Targeted therapy for hepatocellular carcinoma: novel agents on the horizon. (Articolo in rivista) (Prodotto della ricerca)
- Novel combination of sorafenib and celecoxib provides synergistic anti-proliferative and pro-apoptotic effects in human liver cancer cells. (Articolo in rivista) (Prodotto della ricerca)
- Development of nimesulide loaded solid lipid nanoparticles. (Abstract/Poster in atti di convegno) (Prodotto della ricerca)
- Coautore
- Ha pubblicazioni con
- Ha afferente
- Partecipazione di
- Rapporto con persona
